Kerala Daily

Gout Market is Expected to Expand at a Healthy Growth Rate by (2022-2032), States DelveInsight | Key Companies – Selecta Biosciences, Arthrosi Therapeutics

 Breaking News
  • No posts were found

Gout Market is Expected to Expand at a Healthy Growth Rate by (2022-2032), States DelveInsight | Key Companies – Selecta Biosciences, Arthrosi Therapeutics

October 19
01:35 2022
Gout Market is Expected to Expand at a Healthy Growth Rate by (2022-2032), States DelveInsight | Key Companies - Selecta Biosciences, Arthrosi Therapeutics
The Gout market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Gout pipeline products will significantly revolutionize the Gout market dynamics.

DelveInsight’s “Gout Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Gout, historical and forecasted epidemiology as well as the Gout market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

The Gout market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.

 

To Know in detail about the Gout market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Gout Market Insights

 

Gout Overview

Gout is a common form of inflammatory arthritis. It’s due to a crystal called uric acid. Gout causes pain and swelling in one or more joints. It typically affects the big toe. But it’s also found in other joints, including the knee, ankle, foot, hand, wrist and elbow. It is more common in men than in women. Gout usually develops in middle age.

 

Some of the key facts of the Gout Market Report: 

  • The Gout market size is anticipated to grow with a significant CAGR during the study period (2019-2032) 
  • In a study based on US National Health and Nutrition Examination Survey [NHANES] (n.d.), conducted in, 3.9% of the US population reported physician-diagnosed prevalent gout. The male to female ratio was 3:1 
  • In the UK, based on the Clinical Practice Research Data link (CPRD), the prevalence of gout was 2.49% (95% CI, 2.48−2.51%) 
  • Key Gout Companies: Selecta Biosciences, Arthrosi Therapeutics, and others
  • Key Gout Therapies: SEL-212, AR882, and others 
  • The Gout epidemiology based on gender analyzed that the prevalence of Gout is higher in men than in women. Men can be three times more likely than women to get it because they have higher levels of uric acid most of their lives. Women reach these uric acid levels after menopause 

 

Get a Free sample for the Gout Market Report 

 

Key benefits of the Gout Market report:

  1. Gout market report covers a descriptive overview and comprehensive insight of the Gout Epidemiology and Gout market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
  2. The Gout market report provides insights on the current and emerging therapies.
  3. Gout market report provides a global historical and forecasted market covering drug outreach in 7MM.
  4. The Gout market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Gout market.

 

Download the report to understand which factors are driving Gout epidemiology trends @ Gout Epidemiological Insights 

 

Gout Market  

The dynamics of the Gout market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032.  

 

SEL-212, AR882 and other emerging therapies are giving positive topline results, in their clinicaltrials. These emerging therapies are in mid phase of its clinical trials and are awaiting a launchwhich will make the pipeline for Gout robust.” 

 

Gout Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Gout Epidemiology Segmentation:

The Gout market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total Prevalence of Gout
  • Prevalent Cases of Gout by severity
  • Gender-specific Prevalence of Gout
  • Diagnosed Cases of Episodic and Chronic Gout

 

Gout Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Gout market or expected to get launched during the study period. The analysis covers Gout market uptake by drugs, patient uptake by therapies, and sales of each drug.  

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Gout Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Discover more about therapies set to grab major Gout market share @ Gout market forecast 

 

Gout Therapies and Key Companies

  • SEL-212: Selecta Biosciences
  • AR882: Arthrosi Therapeutics

 

Scope of the Gout Market Report

  • Study Period: 2019–2032
  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Gout Companies: Selecta Biosciences, Arthrosi Therapeutics, and others
  • Key Gout Therapies: SEL-212, AR882, and others
  • Gout Therapeutic Assessment: Gout current marketed and Gout emerging therapies
  • Gout Market Dynamics: Gout market drivers and Gout market barriers 
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Gout Unmet Needs, KOL’s views, Analyst’s views, Gout Market Access and Reimbursement 

 

Table of Contents 

1. Gout Market Report Introduction

2. Executive Summary for Gout

3. SWOT analysis of Gout

4. Gout Patient Share (%) Overview at a Glance

5. Gout Market Overview at a Glance

6. Gout Disease Background and Overview

7. Gout Epidemiology and Patient Population

8. Country-Specific Patient Population of Gout 

9. Gout Current Treatment and Medical Practices

10. Gout Unmet Needs

11. Gout Emerging Therapies

12. Gout Market Outlook

13. Country-Wise Gout Market Analysis (2019–2032)

14. Gout Market Access and Reimbursement of Therapies

15. Gout Market Drivers

16. Gout Market Barriers

17.  Gout Appendix

18. Gout Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

To know more about Gout treatment, visit @ Gout Medications

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: Send Email
Phone: +91 9568243403
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com